Competitive Intelligence - Favourable Areas of Strength for Life Science Development in Sweden
|Coordinator||Helidor Consulting AB|
|Funding from Vinnova||SEK 350 000|
|Project duration||October 2018 - January 2019|
Purpose and goal
The objective of the project was to identify and describe national areas of strength favourable for the Swedish life science sector. The purpose is to clarify Sweden´s strengths to international stakeholders, in order to attract capital and competence, and to national investors and decision-makers to provide guidance for aimed investments and strategic development planning. The aim was to identify areas of strength with impact on life science, where Sweden stands out internationally, and to describe the underlying factors which affect the future realisation of each area.
Expected results and effects
The project resulted in the identification of eleven areas of strengths, each of which affect Swedish life science: - Ability to collaborate - Available competence - Innovation clusters - Innovation financing - Research infrastructures - Health data, national registers and biobanks - Preventive healthcare - Biotechnology development - Precision medicine - Biopharmaceuticals - Trademarks Underlying factors affecting each area have been assessed. The results can provide guidance for aimed investments and future strategic planning to promote Swedish life science development.
Planned approach and implementation
The project included qualitative data collection based on literature studies and interviews with national and international stakeholders with insight into the Swedish life science sector. Collected data was categorised into separate areas of strength, and underlying factors were assessed in SWOT analyses. The results were compiled and presented in a written report.